Investment opportunity
$5,000,000 growth financing.
Commercializing nature's nutrient-delivery platform — proving iron first (because nothing works), built to scale across nutrition as a branded ingredient.
Tranche A
$1M
- →Secure commercial rights
- →Complete strategic transactions
- →Conduct human validation
- →Advance regulatory work
- →Initiate product commercialization
Tranche B
$4M
- →Scale ingredient production
- →Build inventory
- →Expand distribution
- →Fund product & ingredient-brand marketing
- →Develop ingredient sales & licensing
Proven models for platform value
Nutrient-delivery technology scales.
PharmaNutra S.p.A.
- •€134 million 2025 revenue
- •~€720 million market capitalization
- •~51% gross margin
- •Distributed across 85 countries
- •Expanded from iron into magnesium, zinc, calcium
Proof that nutrient-delivery technology can scale globally.
Albion Laboratories
- •Acquired by Balchem for US$111.5 million
- •~US$53.5 million in revenue
- •~10.7× EBITDA
- •Built around the Ferrochel branded ingredient
Proof that an ingredient brand can become the strategic asset.
Potential exit path: strategic acquisition by a global ingredient, nutrition, consumer-health, animal-health or pharmaceutical company following human validation, commercial adoption and establishment of the branded ingredient platform.
Register your interest
Investor inquiry
Tell us a little about your firm and we'll follow up with the data room and offering materials.
This page is for information only and is not an offer to sell or a solicitation of an offer to buy any security. Any offering will be made only to eligible investors under available private-placement exemptions and pursuant to definitive offering documents. Statements about future plans are forward-looking and subject to risk. Comparable companies are illustrative and are not a projection of Beyond's results.